Drawing for KLEXALPA

USPTO serial 86501755

KLEXALPA

Reviewed by CopyMark Law Group

Reg. 5253518Status 710
Filing date
Status date
Registration date
Aug 1, 2017
Examiner
HENRY, NAKIA D
Law office
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with KLEXALPA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

Christopher M. Hanes GlaxoSmithKline410 Blackwell StreetLegal Brand ProtectionDurham, NC 27701

Goods and services

ClassDescriptionStatusFirst use
005(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; VaccinesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 16, 2024C8..CANCELLED SEC. 8 (6-YR)—
Nov 8, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 8, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 8, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 8, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 1, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 9, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 1, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 26, 2017DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jun 14, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 23, 2017IUCNNOTICE OF ALLOWANCE CANCELLED—
May 23, 2017EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 8, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 5, 2016EX2GSOU EXTENSION 2 GRANTED—
Oct 13, 2016EXT2SOU EXTENSION 2 FILED—
Oct 13, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 20, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 19, 2016EX1GSOU EXTENSION 1 GRANTED—
May 17, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 14, 2016EXT1SOU EXTENSION 1 FILED—
Apr 14, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 24, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 29, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 9, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 25, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 19, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 19, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 12, 2015ALIEASSIGNED TO LIE—
Jul 29, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 23, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 17, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 17, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Apr 17, 2015CNSLSUSPENSION LETTER WRITTEN—
Apr 17, 2015DOCKASSIGNED TO EXAMINER—
Jan 23, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 16, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance